Auswirkungen von portaler Hypertension und systemischer Entzündung auf Schweregrad und Prognose des akut-auf-chronischen Leberversagens (ACLF)
Gero Kramer(Memorial Sloan Kettering Cancer Center), Benedikt Simbrunner(Austrian Academy of Sciences), Bogdan Procopeț(Iuliu Hațieganu University of Medicine and Pharmacy), Lukas Hartl(Medical University of Vienna), Natalia Dominik(National Hospital for Neurology and Neurosurgery), Philipp Schwabl(Austrian Academy of Sciences), Bernhard Scheiner(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Benedikt Hofer(Austrian Academy of Sciences), Mathias Jachs(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Lorenz Balcar(Medical University of Vienna), Maria Schwarz(Universitätsklinik für Neurologie)
Cited by 0
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k